Table 2.
Stage A(n = 104) | Stage B(n = 73) | Stage C(n = 85) | Stage D(n = 59) | Stage E(n = 26) | |
---|---|---|---|---|---|
Involvement of lesions | |||||
No involvement | 2 (1.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (3.8) |
Single lobe | 16 (15.4) | 5 (6.8) | 8 (9.4) | 6 (10.2) | 3 (11.5) |
Multiple lobes | 86 (82.7) | 68 (93.2) | 77 (90.6) | 53 (89.8) | 22 (84.6) |
GGOs | |||||
None | 24 (23.1) | 19 (27.5) | 21 (24.7) | 14 (24.6) | 7 (28.0) |
Yes | 80 (76.9) | 50 (72.5) | 64 (75.3) | 43 (75.4) | 18 (72.0) |
Consolidation | |||||
None | 26 (25.0) | 16 (21.9) | 14 (16.5) | 26 (45.6) | 21 (84.0) |
Yes | 78 (75.0) | 57 (78.1) | 71 (83.5) | 31 (54.4) | 4 (16.0) |
Data are presented as n (%).
GGOs, ground-glass opacities.